A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial

Soon Jun Hong, Han Saem Jeong, Jeong Cheon Ahn, Dong Hun Cha, Kyung Heon Won, Weon Kim, Sang Kyoon Cho, Seok Yeon Kim, Byung Su Yoo, Ki Chul Sung, Seung Woon Rha, Joon Han Shin, Kyoo Rok Han, Wook Sung Chung, Min Su Hyon, Han Cheol Lee, Jang Ho Bae, Moo Yong Rhee, Jun Kwan, Dong Woon JeonKi Dong Yoo, Hyo Soo Kim

Research output: Contribution to journalArticlepeer-review

24 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences